Casrevolution S.R.L.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Casrevolution S.R.L. - overview

Established

2019

Location

Milan, -, Italy

Primary Industry

Biotechnology

About

Founded in 2019 by Gabriele Grecchi, and based in Milan, Italy, Casrevolution S. R. L. operates as a biotechnology platform that develops a therapeutic drug for patients with Alzheimer’s disease.


In May 2023, Casrevolution S. R. L. , raised EUR 1.


8 million in seed funding led by Utopia sis S. p. A. , with participation from investor Italian Angels for Growth.


The company offers various biotechnology research solutions that help produce therapies for neurodegenerative diseases like Alzheimer’s. The company plans to use the May 2023 funding for research collaborations with the University of Padua and the University of Salerno.


Current Investors

Italian Angels for Growth, UTOPIA SIMPLE INVESTMENT COMPANY

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Casrevolution S.R.L. - financials

Fiscal Year EndedDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Revenue (USD)------
% Revenue Growth (YoY)------
EBITDA (USD)1,210(13,439)2,072---
Operating Income (USD)944(13,705)1,806---
Operating Margin------
% EBITDA Margin------
NET Income (USD)650(13,820)1,806---
% Net Margin------

Casrevolution S.R.L. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.